Zymeworks BC Inc’s recently made public that its Director EcoR1 Capital, LLC acquired Company’s shares for reported $5.85 million on Mar 13 ’25. In the deal valued at $12.48 per share,468,356 shares were bought. As a result of this transaction, EcoR1 Capital, LLC now holds 16,802,141 shares worth roughly $205.83 million.
Then, EcoR1 Capital, LLC bought 320,690 shares, generating $3,685,851 in total proceeds. Upon buying the shares at $11.49, the Director now owns 16,040,851 shares.
Before that, EcoR1 Capital, LLC bought 292,934 shares. Zymeworks BC Inc shares valued at $3,587,826 were divested by the Director at a price of $12.25 per share. As a result of the transaction, EcoR1 Capital, LLC now holds 16,333,785 shares, worth roughly $200.09 million.
JP Morgan upgraded its Zymeworks BC Inc [ZYME] rating to an Overweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who increased its forecast for the stock in early November from “a Market perform” to “an Outperform”. Wells Fargo also remained covering ZYME and has decreased its forecast on November 01, 2024 with a “an Equal weight” recommendation from previously “an Overweight” rating.
Price Performance Review of ZYME
On Friday, Zymeworks BC Inc [NASDAQ:ZYME] saw its stock fall -2.39% to $12.25. Over the last five days, the stock has gained 2.08%. Zymeworks BC Inc shares have fallen nearly -16.33% since the year began. Nevertheless, the stocks have risen 13.32% over the past one year. While a 52-week high of $17.70 was reached on 01/03/25, a 52-week low of $7.97 was recorded on 03/11/25. SMA at 50 days reached $13.89, while 200 days put it at $12.36.
Levels Of Support And Resistance For ZYME Stock
The 24-hour chart illustrates a support level at 11.93, which if violated will result in even more drops to 11.61. On the upside, there is a resistance level at 12.87. A further resistance level may holdings at 13.49. The Relative Strength Index (RSI) on the 14-day chart is 42.01, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.27, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 58.52%. Stochastics %K at 42.05% indicates the stock is a holding.
How much short interest is there in Zymeworks BC Inc?
A steep rise in short interest was recorded in Zymeworks BC Inc stocks on 2025-02-28, dropping by -0.42 million shares to a total of 3.96 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 4.38 million shares. There was a decline of -10.52%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 04, 2023 when H.C. Wainwright resumed its ‘”a Neutral”‘ rating for the stock and retained the price target to $8.
